CHIARION SILENI, VANNA
CHIARION SILENI, VANNA
A comparative study of the cutaneous side effects between BRAF monotherapy and BRAF/MEK inhibitor combination therapy in patients with advanced melanoma: A single-centre experience
2017 Russo, Irene; Zorzetto, Ludovica; Frigo, Anna Chiara; Chiarion Sileni, Vanna; Alaibac, Mauro
A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients
2020 Rastrelli, Marco; Del Fiore, Paolo; Buja, Alessandra; Vecchiato, Antonella; Rossi, Carlo Riccardo; Chiarion Sileni, Vanna; Tropea, Saveria; Russano, Francesco; Zorzi, Manuel; Spina, Romina; Cappellesso, Rocco; Mazzarotto, Renzo; Cavallin, Francesco; Bassetto, Franco; Bezzon, Elisabetta; Ferrazzi, Beatrice; Alaibac, Mauro; Mocellin, Simone
BRAF gene copy number and mutant allele frequency correlate with time to progression in metastatic melanoma patients treated with MAPK inhibitors
2018 Stagni, Camilla; Zamuner, Carolina; Elefanti, Lisa; Zanin, Tiziana; Bianco, Paola Del; Sommariva, Antonio; Fabozzi, Alessio; Pigozzo, Jacopo; Mocellin, Simone; Montesco, Maria Cristina; Chiarion-Sileni, Vanna; DE NICOLO, Arcangela; Menin, Chiara
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC)
2022 Pasello, Giulia; Fabricio, Aline Sueli Coelho; Del Bianco, Paola; Favaretto, Adolfo; Salizzato, Valentina; Piccin, Luisa; Zustovich, Fable; De Rossi, Costanza; Pigozzo, Jacopo; Fabozzi, Alessio; Benetti, Beatrice; Tiozzo Fasiolo, Laura; Bonanno, Laura; Guarneri, Valentina; De Salvo, Gian Luca; Palleschi, Dario; Gion, Massimo; Chiarion-Sileni, Vanna
Clinical Electrochemotherapy for advanced superficial melanoma
2014 Campana, LUCA GIOVANNI; Sundararajan, R.; CHIARION SILENI, Vanna; Rossi, CARLO RICCARDO
Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab
2016 Damuzzo, Vera; Solito, Samantha; Pinton, Laura; Carrozzo, ANNA ELEONORA; Valpione, Sara; Pigozzo, Jacopo; ARBORETTI GIANCRISTOFARO, Rosa; CHIARION SILENI, Vanna; Mandruzzato, Susanna
Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep 2020-May 2021) in the Veneto Oncology Network: The ROVID study
2022 Dieci, Maria V; Azzarello, Giuseppe; Zagonel, Vittorina; Bassan, Franco; Gori, Stefania; Aprile, Giuseppe; Chiarion-Sileni, Vanna; Lonardi, Sara; Oliani, Cristina; Zaninelli, Marta; Chiari, Rita; Favaretto, Adolfo; Pavan, Alberto; Di Liso, Elisabetta; Mioranza, Eleonora; Baldoni, Alessandra; Bergamo, Francesca; Maruzzo, Marco; Ziampiri, Stamatia; Inno, Alessandro; Graziani, Filomena; Sinigaglia, Giusy; Celestino, Michele; Conte, Pierfranco; Guarneri, Valentina
Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells
2019 Scaini, Maria Chiara; Pigozzo, Jacopo; Pizzi, Marco; Manicone, Mariangela; Chiarion-Sileni, Vanna; Zambenedetti, Pamela; Rugge, Massimo; Zanovello, Paola; Rossi, Elisabetta; Zamarchi, Rita; Facchinetti, Antonela
Cost-effectiveness of a melanoma screening programme using whole disease modelling
2020 Buja, Alessandra; Rivera, Michele; Girardi, Giovanni; Vecchiato, Antonella; Rebba, Vincenzo; Pizzo, Elena; Sileni, Vanna Chiarion; Palozzo, Angelo Claudio; Montesco, Maria; Zorzi, Manuel; Sartor, Gino; Scioni, Manuela; Bolzan, Mario; Fiore, Paolo Del; Bonavina, Maria Giuseppina; Rugge, Massimo; Baldo, Vincenzo; Rossi, Carlo Riccardo
Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma
2018 Russo, Irene; Zorzetto, Ludovica; Chiarion Sileni, Vanna; Alaibac, Mauro
Estimation of direct costs of melanoma in the Veneto Region: a budget assessment and cost-consequence analysis
2020 Buja, Alessandra; Sartor, Gino; Scioni, Manuela; Girardi, Giovanni; Vecchiato, Antonella; Bolzan, Mario; Rebba, Vincenzo; Chiarion Sileni, Vanna; Palozzo, Angelo C; Montesco, Maria; Del Fiore, Paolo; Baldo, Vincenzo; Rossi, Carlo R
Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study
2015 Boldrin, Elisa; Rumiato, E.; Fassan, Matteo; Rugge, Massimo; Cagol, M.; Marino, D.; CHIARION SILENI, Vanna; Ruol, A.; Gusella, M.; Pasini, F.; Amadori, Alberto; Saggioro, D.
Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysis
2017 Pasquali, Sandro; CHIARION SILENI, Vanna; Rossi, CARLO RICCARDO; Mocellin, Simone
Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach
2022 Catoni, Cristina; Poggiana, Cristina; Facchinetti, Antonella; Pigozzo, Jacopo; Piccin, Luisa; Chiarion-Sileni, Vanna; Rosato, Antonio; Minervini, Giovanni; Scaini, Maria Chiara
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel
2022 Spada, Francesca; Bossi, Paolo; Caracò, Corrado; Sileni, Vanna Chiarion; Dei Tos, Angelo Paolo; Fazio, Nicola; Grignani, Giovanni; Maio, Michele; Quaglino, Pietro; Queirolo, Paola; Ascierto, Paolo Antonio
PD-L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
2019 Fassan, M.; Cavallin, F.; Guzzardo, V.; Kotsafti, A.; Scarpa, M.; Cagol, M.; Chiarion-Sileni, V.; Maria Saadeh, L.; Alfieri, R.; Castagliuolo, I.; Rugge, M.; Castoro, C.; Scarpa, M.
Per- and polyfluoroalkyl substances (PFAS) exposure in melanoma patients: a retrospective study on prognosis and histological features
2022 Del Fiore, Paolo; Cavallin, Francesco; Mazza, Marcodomenico; Benna, Clara; Monico, Alessandro Dal; Tadiotto, Giulia; Russo, Irene; Ferrazzi, Beatrice; Tropea, Saveria; Buja, Alessandra; Cozzolino, Claudia; Cappellesso, Rocco; Nicolè, Lorenzo; Piccin, Luisa; Pigozzo, Jacopo; Chiarion-Sileni, Vanna; Vecchiato, Antonella; Menin, Chiara; Bassetto, Franco; DEI TOS, Angelo; Alaibac, Mauro; Mocellin, Simone
Prognostic factors in merkel cell carcinoma: A retrospective single-center study in 90 patients
2018 Rastrelli, Marco; Ferrazzi, Beatrice; Cavallin, Francesco; Sileni, Vanna Chiarion; Pigozzo, Jacopo; Fabozzi, Alessio; Tropea, Saveria; Vecchiato, Antonella; Costa, Alessandra; Parisi, Alessandro; Rossi, Carlo Riccardo; Del Fiore, Paolo; Alaibac, Mauro
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity
2019 Turato, Cristian; Scarpa, Melania; Kotsafti, Andromachi; Cappon, Andrea; Quarta, Santina; Biasiolo, Alessandra; Cavallin, Francesco; Trevellin, Elisabetta; Guzzardo, Vincenza; Fassan, Matteo; Chiarion-Sileni, Vanna; Castoro, Carlo; Rugge, Massimo; Vettor, Roberto; Scarpa, Marco; Pontisso, Patrizia
Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
2018 Valpione, Sara; Pasquali, Sandro; Campana, Luca Giovanni; Piccin, Luisa; Mocellin, Simone; Pigozzo, Jacopo; Chiarion-Sileni, Vanna